| Dr David Lee Jordan, OD | |
|
2601 Jewella, Shreveport, LA 71109 | |
| (318) 631-5511 | |
| Not Available |
| Full Name | Dr David Lee Jordan |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 2601 Jewella, Shreveport, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730143371 | NPI | - | NPPES |
| 1314561 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 8931017 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Lee Jordan, OD 2601 Jewella, Shreveport, LA 71109 Ph: (318) 631-5511 | Dr David Lee Jordan, OD 2601 Jewella, Shreveport, LA 71109 Ph: (318) 631-5511 |
News Archive
At a time when health care costs continue to rise and hospitals are advertising emergency room availability, it is becoming more important to educate consumers on how to best access ER alternatives and receive the same care with less out-of-pocket cost. If a primary care physician isn't available, retail health clinics, walk-in doctor offices and urgent care centers can take less time and cost about the same as a regular doctor visit.
Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study-led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital-found no indication that the approach benefits pediatric patients undergoing heart surgery.
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.
Sen. Max Baucus said Tuesday morning that he hopes to convince President Obama that taxing some employer-provided benefits will help control health care costs, The Associated Press reports.
› Verified 3 days ago
Sam R Silverblatt, Od Apmc Optometrist Medicare: Medicare Enrolled Practice Location: 1803 E 70th St, Shreveport, LA 71105 Phone: 318-798-4000 Fax: 318-798-4001 | |
Dr. Christine M Davis, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 955 Pierremont Rd Ste 400, Shreveport, LA 71106 Phone: 318-868-6118 Fax: 318-666-9927 | |
Look Eyecare Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5848 Line Ave, Shreveport, LA 71106 Phone: 318-865-0017 | |
Lusk Eye Specialists, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 451 Ashley Ridge Blvd, Shreveport, LA 71106 Phone: 318-222-5555 Fax: 318-222-6414 | |
Dr. Bradly Kendall Larson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8889 Jewella Ave Ste C, Shreveport, LA 71118 Phone: 318-686-5227 Fax: 381-686-5283 | |
Weston Whitworth, OD Optometrist Medicare: Medicare Enrolled Practice Location: 8889 Jewella Ave, Shreveport, LA 71118 Phone: 318-686-5227 | |
Dr. Michael David Pickering, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5848 Line Ave, Shreveport, LA 71106 Phone: 318-865-0017 Fax: 318-868-4738 |